Verywell Health on MSN1 年
How Leukemia Is Treated
The treatment for leukemia depends on many factors, including the type, subtype, and stage of the disease, and a person’s age ...
来自MSN7 天
Biocurious: Behind Race Oncology’s quest to prevent chemo from being worse than the disease
Race Oncology hopes its drug candidate can protect the heart from the dangerous effect of chemotherapy. ... Read More The ...
Medscape25 天
With Chemo, Blinatumomab Boosts DFS in Pediatric B-ALL
to chemotherapy greatly boosted 3-year disease-free survival (DFS) in younger pediatric patients with newly diagnosed, standard-risk B-cell acute lymphoblastic leukemia (B-ALL), in a phase 3 ...
The American Journal of Managed Care26 天
Adding Blinatumomab to Chemo Boosts Survival in Common Pediatric Leukemia, Results Show
Giving children with B-cell acute lymphoblastic leukemia (B-ALL) 2 nonsequential doses of blinatumomab (Blincyto; Amgen) between chemotherapy cycles improved disease-free survival (DFS ...
Pharmaceutical Technology2 天
CMN-005 by Benecyte for B-Cell Non-Hodgkin Lymphoma: Likelihood of Approval
CMN-005 is under clinical development by Benecyte and currently in Phase II for B-Cell Non-Hodgkin Lymphoma. According to GlobalData, Phase II drugs for B-Cell Non-Hodgkin Lymphoma have a 36% phase ...